A composite endpoint for systemic sclerosis-associated interstitial lung disease: association with mortality in two clinical trial cohorts

By afschroeder • November 29, 2025

Volkmann ER, Wilhalme H, Good S, Kim GHJ, Goldin J, Roth MD, Tashkin DP. A composite endpoint for systemic sclerosis-associated interstitial lung disease: association with mortality in two clinical trial cohorts. Respir Res. 2025 Nov 28;26(1):337. doi: 10.1186/s12931-025-03401-8. PMID: 41316297; PMCID: PMC12661867.

Tags: DOM STAT, General Internal Medicine, interstitial lung disease, Patient Outcome Assessment, Publications, Pulmonary, Critical Care & Sleep Medicine, Randomized Controlled Trial, Rheumatology, systemic sclerosis

Perioperative Best Practices and Delirium in Patients With Cognitive Impairment

Scharp D, Meyers K, Nadkarni G, Federman A, Sarkisian C, Levin MA, Perry S, Gownivaripally P, Egorova NN, Ouyang Y, Hofer I, Vacas S. Perioperative[...]

Use of Untrained Interpreters in the Inpatient Setting: What Does the Record Show?

Linares M, Novoa-Laurentiev J, Chaitoff A, Jiang N, Ma Y, Fernández L, Zhou L. Use of Untrained Interpreters in the Inpatient Setting: What Does the[...]

Correction: Reaching Veterans Most in Need: Evaluating Engagement in a National Telephone Lifestyle Coaching Program for Veterans

Clair K, Bean-Mayberry B, Chanfreau C, Hurley S, Pear E, Goldstein MG, Kim J, Raffa SD, Moin T, Finley EP, Hamilton A, Farmer MM. Correction:[...]